Qiagen Q3 profit down 38% but raises full-year outlook

 

 U.S.-German biotechnology company Qiagen NV said on Monday that its third-quarter net profit dropped 38%, but it raised its outlook for the full year.

Profit slumped in the quarter to $82 million from $133 million a year ago.

It said it was raising its outlook due to strong results in the first nine months and the outlook for the full year.

It now expects sales of $2.25 billion, up from a previous outlook for at least $2.2 billion.

https://www.marketscreener.com/quote/stock/QIAGEN-N-V-40135659/news/Qiagen-Q3-profit-down-38-but-raises-full-year-outlook-42232728/